AIM ImmunoTech Inc.

AIM ImmunoTech Inc.verified

AIM

Price:

$0.5253

Market Cap:

$1.79M

AIM ImmunoTech Inc., an immuno-pharma company, focuses on the research and development of therapeutics to treat multiple types of cancers, viral diseases, and immune-deficiency disorders in the United States. Its flagship products are Ampligen (rintatolimod), a drug of large macromolecular double-stranded ribonucleic acid molecules to treat chronic fatigue syndrome; and Alferon N Injection (Interferon alfa), a purified, natural-source, glycosylated, multi-species alpha interferon product for the treatment of genital warts. The company is also developing Ampligen for potential treatment of pancreatic, renal cell carcinoma, malignant melanoma, non-small cell lung, ovarian, breast, colorectal, ...[Read more]

Industry

Biotechnology

IPO Date

1995-11-02

Stock Exchange

AMEX

Ticker

AIM

The Enterprise Value as of April 2026 (TTM) for AIM ImmunoTech Inc. (AIM) is 5.75M

According to AIM ImmunoTech Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 5.75M. This represents a change of -58.70% compared to the average of 13.93M of the last 4 quarters.

AIM ImmunoTech Inc. (AIM) Historical Enterprise Value (quarterly & annually)

How has AIM Enterprise Value performed in the past?

The mean historical Enterprise Value of AIM ImmunoTech Inc. over the last ten years is 39.13M. The current 5.75M Enterprise Value has changed 1.37% with respect to the historical average. Over the past ten years (40 quarters), AIM's Enterprise Value was at its highest in in the June 2021 quarter at 225.76M. The Enterprise Value was at its lowest in in the September 2019 quarter at 2.43M.

Quarterly (TTM)
Annual

Average

39.13M

Median

28.38M

Minimum

5.79M

Maximum

111.62M

AIM ImmunoTech Inc. (AIM) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of AIM ImmunoTech Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 1.01%

Maximum Annual Enterprise Value = 111.62M

Minimum Annual Increase = -84.66%

Minimum Annual Enterprise Value = 5.79M

Quarterly (TTM)
Annual
YearEnterprise ValueChange
20255.79M-80.88%
202430.31M-40.27%
202350.73M308.34%
202212.42M-84.66%
202181.02M-27.42%
2020111.62M1.01%
201910.01M-61.87%
201826.26M-0.75%
201726.45M-27.79%
201636.63M-21.86%

AIM ImmunoTech Inc. (AIM) Average Enterprise Value

How has AIM Enterprise Value performed in the past?

The current Enterprise Value of AIM ImmunoTech Inc. (AIM) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

28.94M

5-year avg

36.06M

10-year avg

39.13M

AIM ImmunoTech Inc. (AIM) Enterprise Value vs. Peers

How is AIM’s Enterprise Value compared to its peers?

AIM ImmunoTech Inc.’s Enterprise Value is greater than KALA BIO, Inc. (-5171016.00), less than Oragenics, Inc. (225.55M), greater than Pasithea Therapeutics Corp. (-50025342.00), greater than VYNE Therapeutics Inc. (-13348132.00), greater than Quoin Pharmaceuticals, Ltd. (-3814443489.00), greater than Ensysce Biosciences, Inc. (-4003642524529.00), less than XTL Biopharmaceuticals Ltd. (7.46M), greater than Alaunos Therapeutics, Inc. (4.66M), less than Can-Fite BioPharma Ltd. (8.88B), greater than Soligenix, Inc. (-4068789.00),

Build a custom stock screener for AIM ImmunoTech Inc. (AIM) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like AIM ImmunoTech Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

AIM ImmunoTech Inc. (AIM) and other stocks custom spreadsheet templates

The easiest way to analyze a company like AIM ImmunoTech Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is AIM ImmunoTech Inc.'s Enterprise Value?

What is the highest Enterprise Value for AIM ImmunoTech Inc. (AIM)?

What is the 3-year average Enterprise Value for AIM ImmunoTech Inc. (AIM)?

What is the 5-year average Enterprise Value for AIM ImmunoTech Inc. (AIM)?

How does the current Enterprise Value for AIM ImmunoTech Inc. (AIM) compare to its historical average?